NCT02381548 2026-01-30Phase I Trial of AZD1775 and Belinostat in Treating Patients With Relapsed or Refractory Myeloid Malignancies or Untreated Acute Myeloid LeukemiaNational Cancer Institute (NCI)Phase 1 Terminated20 enrolled